IB
Intellicell Biosciences, Inc. Stock: price and insider trades · United States
Intellicell Biosciences, Inc.: what insiders have been doing
Insider filings for Intellicell Biosciences, Inc. are scarce in the SEC (Form 4) feed, the latest one published on 14 September 2012. This page will fill in as new trades are disclosed. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
2
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Last declaration on 14 September 2012
Declarations2 total
- 500,000 shares0Common Stock, par value $0.001 per shareSEC:0001013762-12-001837:0
- 1,000,000 shares0Common Stock, par value $0.001 per shareSEC:0001013762-12-001837:1
2 of 2 declarations
About Intellicell Biosciences, Inc.
Intellicell Biosciences, Inc. is a company focused on developing cellular treatment technologies. It concentrates on applications in the field of regenerative medicine and cellular therapies.
